Recent breakthroughs in immunotherapy have revolutionized the treatment landscape for patients with advanced melanoma. However, matching patients with the appropriate immunotherapy requires incorporating evidence-based guidelines and patient-, drug-, and disease-specific factors to individualize care. In this on-demand video, join our experts for a discussion on evidence-based immunotherapy treatment selection and sequencing, adverse event management, and variables to consider when matching treatment in advanced melanoma. Participate in interactive polls featuring real-world clinical cases and apply your skills in matching patients with the right immunotherapy.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/melanoma-match-treatment-challenge-grand-round-series-advancing-evidence
- Start Date: 2024-12-13 06:00:00
- End Date: 2024-12-13 06:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Merck (Any division) - Amount: 89750.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all